Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TasP and PrEP for HIV Prevention in Female Sex Workers in Benin
NCT02237027Phase 4Completed
- Sponsor
- CHU de Québec-Université Laval
- Start
- Oct 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by CHU de Québec-Université Laval. Started Oct 2014; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02237027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02237027.